Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging

Cancer Immunology, Immunotherapy

Volumn 63, Issue 6, 2014, Pages 615-626

  Farazi, Michelle ^a   Nguyen, Justine ^a   Goldufsky, Josef ^a   Linnane, Stephanie ^a   Lukaesko, Lisa ^b   Weinberg, Andrew D ^b   Ruby, Carl E ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

Aging; Caloric restriction; Immunotherapy; Resveratrol; T cell

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOMODULATING AGENT; OX40 AGONIST; OX40 LIGAND; RESVERATROL; UNCLASSIFIED DRUG;

AGE; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BREAST TUMOR; CALORIC RESTRICTION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; IMMUNE RESPONSE; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SARCOMA; TUMOR IMMUNITY;

ADOPTIVE TRANSFER; AGING; ANIMALS; ANTICARCINOGENIC AGENTS; BLOTTING, WESTERN; CALORIC RESTRICTION; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; RECEPTORS, OX40; STILBENES; SURVIVAL RATE; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY;

EID: 84901612711     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-014-1542-y     Document Type: Article

References (47)

1. Dudley ME, Wunderlich JR, Robbins PF et al (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298:850-854. doi: 10.1126/science.1076514
2. Topalian SL, Hodi FS, Brahmer JR et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366:2443-2454. doi: 10.1056/NEJMoa1200690
3. Scollay RG, Butcher EC, Weissman IL (1980) Thymus cell migration: quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur J Immunol 10:210-218
4. Haynes L, Linton PJ, Eaton SM, Tonkonogy SL, Swain SL (1999) Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med 190:1013-1024
5. Effros RB, Walford RL (1983) The immune response of aged mice to influenza: diminished T-cell proliferation, interleukin 2 production and cytotoxicity. Cell Immunol 81:298-305
6. Kovacs EJ, Palmer JL, Fortin CF, Fulop T Jr, Goldstein DR, Linton PJ (2009) Aging and innate immunity in the mouse: impact of intrinsic and extrinsic factors. Trends Immunol 30:319-324. doi: 10.1016/j.it.2009.03.012
7. Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S (2007) Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol 178:6912-6922
8. Franceschi S, La Vecchia C (2001) Cancer epidemiology in the elderly. Crit Rev Oncol Hematol 39:219-226
9. Anisimov VN (2009) Carcinogenesis and ageing 20 years after: escaping horizon. Mech Ageing Dev 130:105-121. doi: 10.1016/j.mad.2008.02.004
10. Castro F, Leal B, Denny A, Bahar R, Lampkin S, Reddick R, Lu S, Gravekamp C (2009) Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer. Br J Cancer 101:1329-1337. doi: 10.1038/sj.bjc.6605329
11. Ruby CE, Weinberg AD (2009) OX40-enhanced tumor rejection and effector T cell differentiation decreases with age. J Immunol 182:1481-1489
12. Morris NP, Peters C, Montler R, Hu HM, Curti BD, Urba WJ, Weinberg AD (2007) Development and characterization of recombinant human Fc: OX40L fusion protein linked via a coiled-coil trimerization domain. Mol Immunol 44:3112-3121. doi: 10.1016/j.molimm.2007.02.004
13. Nikolich-Zugich J, Messaoudi I (2005) Mice and flies and monkeys too: caloric restriction rejuvenates the aging immune system of non-human primates. Exp Gerontol 40:884-893. doi: 10.1016/j.exger.2005.06.007
14. Effros RB, Svoboda K, Walford RL (1991) Influence of age and caloric restriction on macrophage IL-6 and TNF production. Lymphokine Cytokine Res 10:347-351
15. Pahlavani MA (2004) Influence of caloric restriction on aging immune system. J Nutr Health Aging 8:38-47
16. Walford RL, Liu RK, Gerbase-Delima M, Mathies M, Smith GS (1973) Longterm dietary restriction and immune function in mice: response to sheep red blood cells and to mitogenic agents. Mech Ageing Dev 2:447-454
17. Messaoudi I, Warner J, Fischer M et al (2006) Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates. Proc Natl Acad Sci USA 103:19448-19453. doi: 10.1073/pnas.0606661103
18. Howitz KT, Bitterman KJ, Cohen HY et al (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-196. doi: 10.1038/nature01960
19. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506. doi: 10.1038/nrd2060
20. Harikumar KB, Aggarwal BB (2008) Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7:1020-1035
21. Lavu S, Boss O, Elliott PJ, Lambert PD (2008) Sirtuins-novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov 7:841-853. doi: 10.1038/nrd2665
22. Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951
23. Gao X, Deeb D, Media J, Divine G, Jiang H, Chapman RA, Gautam SC (2003) Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects. Biochem Pharmacol 66:2427-2435
24. Docherty JJ, Fu MM, Hah JM, Sweet TJ, Faith SA, Booth T (2005) Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. Antiviral Res 67:155-162. doi: 10.1016/j.antiviral.2005.06.008
25. Lu CC, Lai HC, Hsieh SC, Chen JK (2008) Resveratrol ameliorates Serratia marcescens-induced acute pneumonia in rats. J Leukoc Biol 83:1028-1037. doi: 10.1189/jlb.090764
26. Soto BL, Hank JA, Van De Voort TJ et al (2011) The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model. Cancer Immunol Immunother 60:731-738. doi: 10.1007/s00262-011-0971-0
27. Pearson KJ, Baur JA, Lewis KN et al (2008) Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8:157-168. doi: 10.1016/j.cmet.2008.06.011
28. Schneider Y, Vincent F, Duranton B, Badolo L, Gosse F, Bergmann C, Seiler N, Raul F (2000) Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett 158:85-91
29. Rimando AM, Cuendet M, Desmarchelier C, Mehta RG, Pezzuto JM, Duke SO (2002) Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem 50:3453-3457
30. Joseph JA, Fisher DR, Cheng V, Rimando AM, Shukitt-Hale B (2008) Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging. J Agric Food Chem 56:10544-10551. doi: 10.1021/jf802279h
31. Lin HS, Yue BD, Ho PC (2009) Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed Chromatogr 23:1308-1315. doi: 10.1002/bmc.1254
32. Pereira LF, de Souza AP, Borges TJ, Bonorino C (2011) Impaired in vivo CD4+ T cell expansion and differentiation in aged mice is not solely due to T cell defects: decreased stimulation by aged dendritic cells. Mech Ageing Dev 132:187-194. doi: 10.1016/j.mad.2011.03.005
33. Lefebvre JS, Maue AC, Eaton SM, Lanthier PA, Tighe M, Haynes L (2012) The aged microenvironment contributes to the age-related functional defects of CD4 T cells in mice. Aging Cell 11:732-740. doi: 10.1111/j.1474-9726.2012.00836.x
34. Kjaergaard J, Tanaka J, Kim JA, Rothchild K, Weinberg A, Shu S (2000) Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth. Cancer Res 60:5514-5521
35. Webster RG (2000) Immunity to influenza in the elderly. Vaccine 18:1686-1689
36. Bansal-Pakala P, Halteman BS, Cheng MH, Croft M (2004) Costimulation of CD8 T cell responses by OX40. J Immunol 172:4821-4825
37. Ruby CE, Redmond WL, Haley D, Weinberg AD (2007) Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses. Eur J Immunol 37:157-166. doi: 10.1002/eji.200636428
38. Shortman K, Heath WR (2010) The CD8+ dendritic cell subset. Immunol Rev 234:18-31. doi: 10.1111/j.0105-2896.2009.00870.x
39. Leon B, Lopez-Bravo M, Ardavin C (2007) Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26:519-531. doi: 10.1016/j.immuni.2007. 01.017
40. Nakano H, Lin KL, Yanagita M, Charbonneau C, Cook DN, Kakiuchi T, Gunn MD (2009) Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat Immunol 10:394-402. doi: 10.1038/ni.1707
41. Weindruch R (1989) Dietary restriction, tumors, and aging in rodents. J Gerontol 44:67-71
42. Sharma S, Dominguez AL, Lustgarten J (2006) Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp Gerontol 41:78-84. doi: 10.1016/j.exger.2005.10.002
43. Sieri S, Krogh V, Muti P, Micheli A, Pala V, Crosignani P, Berrino F (2002) Fat and protein intake and subsequent breast cancer risk in postmenopausal women. Nutr Cancer 42:10-17
44. Jang M, Cai L, Udeani GO et al (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220
45. Baur JA (2010) Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 131:261-269. doi: 10.1016/j.mad.2010.02.007
46. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377-1382. doi: 10.1124/dmd.104.000885
47. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP (2002) Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 302:369-373